Skip to main content
As of the 24 September 2015 The Centre for Ageing Research and Development in Ireland (CARDI) became the Ageing Research and Development Division within the Institute of Public Health in Ireland (IPH).
This website will remain online but will no longer be updated. To keep up to date with our work please visit the Division of Ageing Research and Development section of the IPH website.
You are here
Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease
1st September 1999, Department of Geriatric Medicine, The Queen's University of Belfast
It has recently been reported that a genetic polymorphism in exon 2 of the cathepsin D gene conferred increased risk for development of Alzheimer's disease (AD). Because of the potential importance of this report we tested this association in a clinically well-defined group of AD patients and age and sex matched control subjects from the relatively genetically homogeneous Northern Ireland population. This study failed to confirm the reported association between the cathepsin D exon 2 polymorphism and AD. We conclude that if an association exists between this polymorphism and AD it is likely to be small.